Metastatic lung adenocarcinoma harboring an ERBB2 exon 20 insertion and low-level copy-number gain: hyperprogression after immunotherapy and sequential HER2-directed ADC therapy—a case report
BackgroundHER2 (ERBB2) alterations in non-small cell lung cancer (NSCLC) comprise a molecularly heterogeneous group, including activating mutations, copy-number gain/amplification, and protein overexpression. HER2 mutation and high-level amplification …